- Genetics of Thyroid Cancer and its Molecular Target Therapy2011 | Central Library of Charles University
- Integration of surgery and molecular targeted therapy in advanced renal cell carcinoma2011 | Second Faculty of Medicine
- Stomatitis in mtor inhibitors treatment and other targeted cancer therapy, possibilities of influencing it, and the use of local corticotherapy2020 | Faculty of Medicine in Pilsen
- Hepatocellular carcinoma - long-term treatable disease2012 | Faculty of Medicine in Pilsen
- Sarcopenia in Metastatic Colorectal Carcinoma2019 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Sarcopenia and colorectal carcinoma2020 | First Faculty of Medicine
- EGFR mutations in patients with advanced NSCLC2012 | Faculty of Medicine in Pilsen
- Durable Complete Response of Colorectal Cancer Metastasis after Biochemotherapy2017 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University, Faculty of Physical Education and Sport
- Oncolytic viruses and cancer treatment2023 | Faculty of Science
- New agent to enhance targeted therapy of metastatic HER2+ breast cancer - pertuzumab2013 | First Faculty of Medicine
- Malignant Melanoma - from Classical Histology towards Molecular Genetic Testing2017 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Importance of Aberrantly Activated Hedgehog/Gli Pathway in Tumour Progression2020 | First Faculty of Medicine
- Patients with neuregulin 1 (NRG1) rearranged cancer are suitable for the theranostic approach and targeted therapy2022 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- New WHO classification of lung tumours2016 | Faculty of Medicine in Pilsen
- Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinib2016 | Faculty of Medicine in Pilsen, Faculty of Science
- Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis2017 | First Faculty of Medicine
- The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer2013 | Faculty of Medicine in Pilsen
- Comparison of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC2013 | Faculty of Medicine in Pilsen
- Second-line treatment of advanced NSCLC: Comparison of efficacy of erlotinib and chemotherapy2013 | Faculty of Medicine in Pilsen
- Assessing prognosis of neuroendocrine neoplasms: Results of a collaborative multinational effort including over 10.000 european patients-The ENETS registryPublication without faculty affiliation